AM REGENT FDA Approval ANDA 070826

ANDA 070826

AM REGENT

FDA Drug Application

Application #070826

Application Sponsors

ANDA 070826AM REGENT

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION160MG/ML0DOPAMINE HYDROCHLORIDEDOPAMINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1987-02-11
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1992-02-05
LABELING; LabelingSUPPL3AP1992-08-26
LABELING; LabelingSUPPL4AP1992-10-27
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1993-06-30
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1996-02-28
LABELING; LabelingSUPPL7AP1996-09-24
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1998-01-07
LABELING; LabelingSUPPL9AP1997-11-07
LABELING; LabelingSUPPL10AP2001-11-07
LABELING; LabelingSUPPL16AP2021-06-21STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL5Null0
SUPPL6Null0
SUPPL8Null0
SUPPL16Null31

CDER Filings

AM REGENT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 70826
            [companyName] => AM REGENT
            [docInserts] => ["",""]
            [products] => [{"drugName":"DOPAMINE HYDROCHLORIDE","activeIngredients":"DOPAMINE HYDROCHLORIDE","strength":"160MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"DOPAMINE HYDROCHLORIDE","submission":"DOPAMINE HYDROCHLORIDE","actionType":"160MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.